Novo Nordisk downgrades sales outlook
Digest more
The real snag will come in the next decade: The U.S. represents 50% of group sales for Novo, and while there is a “good ...
Novo Nordisk’s oral therapy Wegovy (semaglutide) reduced cardiovascular risk factors in the Phase III OASIS 4 trial. Being ...
The White House is nearing an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their ...
Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...
Novo Nordisk stock just crashed -- but new drugs, smart acquisitions, and Wall Street upgrades could set up one of the ...
Pedersen, Maggie Fick and Bhanvi Satija COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year profit and ...
Unlike many other diseases, there are no set guidelines on treatment targets for obesity, and outcomes often rely on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback